Sangamo Therapeutics SGMO Q1 2026 Results Fall Short EPS 008 Revenue NA Value Line VALU Slides 274 as Selling Pressure Mounts 20260513 Snaps Q1 2026 Earnings Highlight Progress But Spotlight Turns to AR Glasses Strategy Birkenstock Faces Cost Pressures from Tariffs and Geopolitical Tensions Duke Energy DUKB Q1 2026 Beat Revenue NA EPS Exceeds by Significant Google Debuts Gemini 35 Flash and AI Agents to Rival OpenAI and Anthropic Arcadia Biosciences RKDA Crushes Q3 2025 Estimates EPS 062 Tops Views TDK Reports Acquisition of Malaysian Startup to Strengthen AI Battery Capacity